Knight

Knight Therapeutics Announces Launch of Minjuvi® in Brazil

Retrieved on: 
Thursday, February 29, 2024

MONTREAL, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today the launch of Minjuvi® (tafasitamab) by its Brazilian affiliate, United Medical Ltda.

Key Points: 
  • MONTREAL, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today the launch of Minjuvi® (tafasitamab) by its Brazilian affiliate, United Medical Ltda.
  • Additionally, in October 2023, Knight received pricing approval for Minjuvi® from the Drugs Market Regulation Chamber (“CMED”).
  • “In line with Knight’s commitment to advancing healthcare in Latin America, we are excited to launch Minjuvi in Brazil, an innovative treatment option for addressing a current unmet medical need,” said Samira Sakhia, Knight Therapeutics President and CEO.
  • “Knight’s team in Brazil is thrilled to make Minjuvi® available to health care professionals and centers, improving DLBCL patient care in the country,” said Cristiane Coelho, Knight Therapeutics Brazil General Manager.

Knight Therapeutics Inc. Celebrates its First Decade of Success

Retrieved on: 
Wednesday, February 28, 2024

MONTREAL, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that it is marking its 10-year anniversary, and celebrating a decade of expansion and growth.

Key Points: 
  • MONTREAL, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that it is marking its 10-year anniversary, and celebrating a decade of expansion and growth.
  • Knight has invested over $925 million to build its unique pan-American (ex US) platform of innovative and branded generic pharmaceuticals.
  • Today, Knight has over 700 talented employees operating in Canada and 10 Latin American markets.
  • Since the completion of the acquisition of Biotoscana, Knight has entered into 11 new partnerships for 13 innovative and branded generic products.

Knight Therapeutics Announces Regulatory Submission of Fostamatinib in Brazil

Retrieved on: 
Wednesday, February 21, 2024

MONTREAL, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltda., has submitted a marketing authorization application to ANVISA, the Brazilian health regulatory agency, for fostamatinib for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment.

Key Points: 
  • MONTREAL, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltda., has submitted a marketing authorization application to ANVISA, the Brazilian health regulatory agency, for fostamatinib for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment.
  • Knight has previously submitted marketing authorization applications for fostamatinib in Colombia and Mexico.
  • “This submission of fostamatinib demonstrates Knight’s continued execution of our strategy of leveraging our solid platform and expertise to bring innovative therapies for important unmet healthcare needs in Latin America,” said Samira Sakhia, President and Chief Executive Officer of Knight Therapeutics Inc.
    On May 24, 2022, Knight announced that it entered into an agreement with Rigel Pharmaceuticals, Inc. for the exclusive rights to commercialize fostamatinib, an oral spleen tyrosine kinase (SYK) inhibitor, in Latin America.
  • Fostamatinib is commercially available in the United States under the brand name TAVALISSE® and in Europe under the brand name TAVLESSE® for the treatment of adult chronic ITP.

Chevron announces its first solar-to-hydrogen production project in California’s Central Valley

Retrieved on: 
Thursday, February 29, 2024

Chevron New Energies, a division of Chevron U.S.A. Inc., announced it is developing a 5-megawatt hydrogen production project in California’s Central Valley.

Key Points: 
  • Chevron New Energies, a division of Chevron U.S.A. Inc., announced it is developing a 5-megawatt hydrogen production project in California’s Central Valley.
  • Chevron believes in the value of delivering large-scale hydrogen solutions that support a lower carbon world.
  • “Chevron already offers lower carbon fuels like sustainable aviation fuel, renewable diesel and others, and this project is expected to expand the portfolio of solutions Chevron could supply to the region.
  • “By locating expected production in the Central Valley, we believe the project will be well positioned to meet the demand of customers along an important transportation corridor, as well as having proximity to key California urban markets.”

PPG ranked as leading paints and coatings manufacturer in 2024 Corporate Knights Clean200 list

Retrieved on: 
Wednesday, February 21, 2024

PPG (NYSE:PPG) today announced that it was named to the 2024 Corporate Knights Clean200 list as the leading paints, coatings and specialty materials manufacturer.

Key Points: 
  • PPG (NYSE:PPG) today announced that it was named to the 2024 Corporate Knights Clean200 list as the leading paints, coatings and specialty materials manufacturer.
  • The company earned the top spot by having a strong percent of 2022 sales from sustainable products, as defined by Corporate Knights.
  • The Clean200 list ranks the 200 publicly traded companies that have the most sustainable total revenue, earning a minimum of 10% from sustainable sources.
  • 161 overall on the list in sustainable revenue, reporting 19% of sales from products with third party sustainability certifications in 2022.

Swiftly Acquires BYBE, Powering the Future of Alcohol Promotions in Retail

Retrieved on: 
Wednesday, March 6, 2024

SEATTLE, March 6, 2024 /PRNewswire/ -- Swiftly, a leading provider of innovative technology tools and solutions, today announced its acquisition of the alcohol promotions platform, BYBE. This strategic move combines BYBE's domain expertise in the alcohol category—including its well-established connections with suppliers, retailers, and regulators with Swiftly's current Alcohol Cashback solution. The acquisition will help Swiftly scale its Alcohol Cashback solution and reach more consumers with adult beverage offers and rebates.

Key Points: 
  • SEATTLE, March 6, 2024 /PRNewswire/ -- Swiftly, a leading provider of innovative technology tools and solutions, today announced its acquisition of the alcohol promotions platform, BYBE.
  • This strategic move combines BYBE's domain expertise in the alcohol category—including its well-established connections with suppliers, retailers, and regulators with Swiftly's current Alcohol Cashback solution.
  • The acquisition will help Swiftly scale its Alcohol Cashback solution and reach more consumers with adult beverage offers and rebates.
  • BYBE's Alcohol Cashback platform will be integrated into Swiftly's product suite, simplifying the process for retailers looking to grow their alcohol market share.

Father of Exactech Employee Receives First Ankle Replacement Using Activit-E™ Polyethylene

Retrieved on: 
Thursday, February 29, 2024

Specifically, he tested results between vitamin E-infused polyethylene and standard polyethylene.

Key Points: 
  • Specifically, he tested results between vitamin E-infused polyethylene and standard polyethylene.
  • Serendipitously, last year Exactech announced Activit-E for the Vantage® Total Ankle System and his father, John Wesley Garrett.
  • Garrett Sr.'s ankle replacement surgery was performed earlier this month by Raymond Rowan, DPM, of Stellar Foot and Ankle in New Smyrna Beach, Fla.
  • Activit-E, with its improved polyethylene wear properties, coupled with the Vantage Total Ankle System, are a winning combination," said Dr. Schipper.

Truist Foundation Inspire Awards registration now open

Retrieved on: 
Monday, February 26, 2024

CHARLOTTE, N.C., Feb. 26, 2024 /PRNewswire/ -- Truist Foundation today announced the opening of registration for its second Inspire Awards to be held on April 24 at the Knight Theater in Charlotte and online. The Inspire Awards is a pitch-style grant program celebrating nonprofits across the country that bring forward innovative solutions to support entrepreneurs from undercapitalized communities.

Key Points: 
  • The Inspire Awards is a pitch-style grant program celebrating nonprofits across the country that bring forward innovative solutions to support entrepreneurs from undercapitalized communities.
  • "I'm honored to be given the opportunity to host the Truist Foundation Inspire Awards this upcoming spring," said Olsen.
  • "The Truist Foundation Inspire Awards is an evening where inspiration meets action, and your registration is the first step."
  • Leading up to the Inspire Awards, Truist Foundation collaborated with Solve , an initiative of the Massachusetts Institute of Technology, to identify and invest in nonprofits leveraging technology as a proven pathway to resiliency and sustainability.

Opteon CEO Named 2024 Valuation Visionary

Retrieved on: 
Tuesday, February 20, 2024

TOLEDO, Ohio, Feb. 20, 2024 /PRNewswire/ -- Opteon, a leading global appraisal management company (AMC) and staff appraisal firm, announced today that Chris Knight, Opteon's Chief Executive Officer, has been chosen as the 2024 Valuation Visionary honoree by the Collateral Risk Network (CRN).

Key Points: 
  • TOLEDO, Ohio, Feb. 20, 2024 /PRNewswire/ -- Opteon , a leading global appraisal management company (AMC) and staff appraisal firm, announced today that Chris Knight, Opteon's Chief Executive Officer, has been chosen as the 2024 Valuation Visionary honoree by the Collateral Risk Network (CRN).
  • Knight is the 15th recipient of the Valuation Visionary award and will be presented with the award during the CRN event at Valuation Expo 2024.
  • Joan Trice, Founder and President of the CRN states, "Chris Knight is a visionary in the appraisal industry.
  • This acquisition enhances ASG's ability to provide innovative valuation products and solutions and strengthens its position as a market leader in the appraisal tech industry.

Burberry Turns Harrods Knight Blue

Retrieved on: 
Thursday, February 1, 2024

LONDON, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Celebrating Burberry’s heritage of exploration and the outdoors, the modern British luxury brand transforms renowned department store Harrods with a month-long knight blue takeover.

Key Points: 
  • At night, Harrods’ exterior will be illuminated in knight blue, a new signature colour of the house introduced by Chief Creative Officer Daniel Lee.
  • Inside Harrods, visitors can explore the Burberry Camping Corner, which offers classic British hiking accessories, including a bespoke knight bottle opener and a hot water bottle.
  • In addition, Burberry has curated a custom Harrods hamper, which features a unique camping-inspired offer complete with a limited-edition Burberry picnic blanket in knight blue.
  • The Harrods’ green men are famed worldwide, and for the takeover, Burberry will spin their traditional green outfits into a knight blue check – a new pattern introduced by Daniel Lee in his Spring 2024 collection.